Back to Anacor Homepage Developing Drug Candidates Through Boron Chemistry
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
Learn more about boron technology
Pipeline

By exploiting the advantages of our boron chemistry platform, we have discovered and advanced into clinical development several novel and proprietary boron-based product candidates that address attractive market opportunities.

[ View pipeline ]

 
Pipeline Graphic
 
 
New Releases

Thursday, May 10, 2012 | Anacor Pharmaceuticals Reports First Quarter 2012 Financial Results
Friday, May 4, 2012 | Anacor Pharmaceuticals to Present Clinical Data on Tavaborole and AN2728 at Upcoming Medical Meetings
Friday, May 4, 2012 | Anacor Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call and Webcast
 
New Releases Graphic
 
 
Scientific Presentations

May 9-12, 2012 - Raleigh, NC

Society for Investigative Dermatology Annual Meeting

March 11-15, 2012 - San Francisco, CA

Society of Toxicology Annual Meeting

October 23-27, 2011 - Washington, DC

American Association of Pharmaceutical Sciences Annual Meeting

October 16-20, 2011 - Atlanta, Georgia

International Society for the Study of Xenobiotics

September 17-20, 2011 - Chicago, IL

51st ICAAC

September 7-10, 2011 - Barcelona, Spain

41st Annual Meeting of the European Society for Dermatological Research